Patients
![[title-raw]](http://www.ahmf.com.au/sites/default/files/images/[type]/teasers/[title-raw]/research-presentation.jpg?1243252450) |
AHMF research to be presented internationally In 2007, the AHMF conducted an online survey to determine how many people were at risk of having herpes. The results are about to be presented to a wide international audience. |
![[title-raw]](http://www.ahmf.com.au/sites/default/files/images/[type]/teasers/[title-raw]/2-day-treatment.jpg?1243252492) |
Two-day treatment course for genital herpes A new two-day course of famciclovir (available in Australia as Famvir) has been licensed for treating outbreaks of genital herpes. The new course consists of a single 500mg dose, followed by three doses of 250mg. |
|
Online survey helps determine those likely to have herpes 36 per cent of survey participants found to be at high risk of contracting the virus. |
